Bioinvent International AB operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioinvent International AB with three other
companies in this sector in Sweden:
sales of 74.92 million Swedish Kronor [US$9.13 million]
(93.04 million Swedish Kronor [US$11.33 million]
of which 100%
was Pharmaceutical), and
Alligator Bioscience Ab
(58.24 million Swedish Kronor [US$7.09 million]
Sales increased substantially in 2016:
Bioinvent International AB reported sales of SEK 71.28 million (US$8.68 million)
December of 2016.
increase of 347.6%
versus 2015, when the company's sales were SEK 15.93 million.